Published On: Mon, Nov 10th, 2014

Drugmaker Stocks Get Fame – Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), AbbVie Inc. (NYSE:ABBV), Zogenix, Inc. (NASDAQ:ZGNX),

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) [Trend Analysis] plunged over 30% in last session after it released its Q3 loss of $35.8M. On a per-share basis, the New York-based firm reported that it had a loss of $1.69. The results dropped short of Wall Street anticipations. The average expects of analysts surveyed by Zacks Investment Research was for a loss of $1.10 a share. Intercept shares have over tripled since the start of the year. The stock has over quadrupled in the perfidious 12 months. Stocks of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) closed at $172.59 in last session with the total traded volume of 4.03 Million. The Financial Institutional ownership of the firm was 61.10% while by insiders was 2.50%.

On Vigorous Sprint, Is NASDAQ:ICPT Going to Bullish or Bearish? Find Out Here

Hedge fund Elliott Associates could take lawful action against pharmaceuticals firm AbbVie Inc. (NYSE:ABBV) [Trend Analysis] for scuttling a merger contract with Shire Plc. Elliott reported in a quarterly letter to investors so as to it was dissatisfied when AbbVie’s board withdrew its support for the deal in October after executives had signaled strong interest in late September. The fund wrote in the letter, which was seen by Reuters articulated that they are exploring their options with respect to this matter, comprises whether to assert claims against AbbVie for making false and misleading statements about the transaction. AbbVie Inc. (NYSE:ABBV) stock finished trading at $61.50 in last trading day with market capitalization of 97.889 Billion. The stock has a 52-week high price of $63.99 and its 52-week low was recorded at $45.50.

How NYSE:ABBV Taste Ups And Down- Find Out Here

Zogenix, Inc. (NASDAQ:ZGNX) [Trend Analysis] recently declared financial results for the Q3 ended September 30, 2014. Ann Rhoads, CDO of Zogenix, stated that in conjunction with the acquisition of Brabant Pharma, they signed a non-binding term sheet for a $20M term loan and a $4M revolving line of credit. Zogenix, Inc. (NASDAQ:ZGNX) after opening at $1.38 hit its intraday high price of $1.39 moreover then finished at $1.32 as shares moving down -2.22%. As took noticed on the firm performance, its weekly performance was 3.94%, monthly performance was 9.09%. The stock price of ZGNX is moving up from its 20 days moving average with 2.33% and isolated positively from 50 days moving average with 4.71%.

Why NASDAQ:ZGNX on Bearish Notes in Eye of Experts? Find Inside Facts Here

Read Full Disclaimer Here

Displaying 1 Comments
Have Your Say
  1. Damon Verial says:

    ICPT: Sell iron butterflies

    ABBV: Buy bull debit spreads with a target price of 69

    ZGNX: Sell iron butterflies

    Note that ICPT has a gap in it. But it’s unlikely to break out in either direction. If you’re worried about risk, just stay out for the time being.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>